Pharmacy and Biomedical Sciences
Dr David Laight FHEA
Senior Lecturer
Pharmacy and Biomedical Sciences
Division of Pharmacology
School of Pharmacy and Biomedical Sciences
University of Portsmouth
St Michael's Building
White Swan Road
Portsmouth
PO1 2DT
Profile
Qualifications
- BSc
- PhD
- PG Cert.Ed
Internal memberships / posts
- Unit Coordinator
- Induction Tutor (PHBM)
- Year 2 Tutor (BSc Pharmacology)
- Facilitator for inter-professional learning
External memberships
- Fellow of the Higher Education Academy (FHEA)
Key teaching responsibilities
- Year 1: Introduction to cardiovascular system, renal system & blood
- Year 2: Physiology and pharmacology of renal & cardiovascular systems, autacoids, lipids & diabetes mellitus pathophysiology & therapeutics
- Year 3/4: Undergraduate project supervision
Key research interests
Oxidative stress, endothelial dysfunction, cardiovascular disease, diabetes mellitus, cystic fibrosis, copper aminoglycosides, antioxidants, organ preservation;
Supervisor for postgraduate students at PhD and MD level;
Clinical collaboration with Portsmouth Hospitals NHS Trust in diabetes (The Portsmouth Dysglycaemia, Oxidative Stress and the Vascular Endothelium (DOVE) Project).
Recent Publications
More recent publications
Publications before 2006
Laight DW, Therapeutic approaches to organ preservation injury, Expert Opin. Ther. Patents, in press 2005.
Fayers K, Cummings MH, Shaw KM & Laight DW, Nitrate tolerance and the links with endothelial dysfunction and oxidative stress, Br. J. Clin. Pharmacol., 56, 620-628, 2003.
Wotherspoon F, Laight DW, Shaw KM & Cummings MH, Homocysteine, endothelial dysfunction and oxidative stress in type 1 diabetes mellitus, Br. J. Diabetes Vasc. Dis., 3, 334-340, 2003.
Laight DW, Therapeutic approaches to the management of dysmetabolic cardiovascular disease. Expert Opin. Ther. Patents, 12, 615-620, 2002.
Laight DW, Desai KM, Anggard EE & Carrier MJ, Endothelial dysfunction accompanies a pro-oxidant, pro-diabetic challenge in the insulin resistant obese Zucker rat in vivo, Eur. J. Pharmacol., 402, 95-99 2000.